| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/19/2001 | CN1313767A Carbamate and urea compositions and neurotrophic uses |
| 09/19/2001 | CN1313756A Oral liquid mucoadhesive compositions |
| 09/19/2001 | CN1313754A Oral liquid mucoadhesive compositions |
| 09/19/2001 | CN1313343A N-terminal modified protein compositions and methods therefor |
| 09/19/2001 | CN1313280A Benzheterocyclic derivatives |
| 09/19/2001 | CN1313123A Sancao analgesic |
| 09/19/2001 | CN1313121A Medicine for treating sciatic nerve diseases |
| 09/19/2001 | CN1313119A Medicinal particles for treating diabetic peripheral neuropathy |
| 09/19/2001 | CN1313113A Medicine for treating mental diseases (psychosis) |
| 09/19/2001 | CN1313108A Composite non-opium medicine for dropping drugs |
| 09/19/2001 | CN1071329C Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/19/2001 | CN1071328C Arginine angalogues having nitric oxide synthase inhibitor activity |
| 09/19/2001 | CN1071318C Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same |
| 09/19/2001 | CN1071315C Carbamate compounds and processes for preparing the same |
| 09/19/2001 | CN1071309C 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients |
| 09/19/2001 | CN1071116C Paroxetine tablets and process to prepare them |
| 09/18/2001 | US6291689 Cyclizing 4-cyano-2-hydroxymethylphenyl)(4-fluorophenyl)methanol to form 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile; alkylating to form citalopram |
| 09/18/2001 | US6291672 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 09/18/2001 | US6291643 Apaf-1 an activator of caspase-3 |
| 09/18/2001 | US6291523 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 09/18/2001 | US6291516 Contacting the cell with a composition including at least one cyclic amp agonist. |
| 09/18/2001 | US6291505 Pyrazole estrogen receptor agonist and antagonist |
| 09/18/2001 | US6291499 2-cyclohexyl benzimidazole NMDA/NR2B antagonists |
| 09/18/2001 | US6291494 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use |
| 09/18/2001 | US6291473 Treating anxiety, depression, post-traumatic stress disorder, inflammatory diseases, obesity, in mammals |
| 09/18/2001 | US6291467 Heteroaromatic derivatives |
| 09/18/2001 | US6291466 Cholinergic agents in the treatment of presbyopia |
| 09/18/2001 | US6291465 Biphenyl derivatives |
| 09/18/2001 | US6291464 Aminopiperazine derivatives |
| 09/18/2001 | US6291460 Treatment of anxiety; treatment and/or prevention of convulsions |
| 09/18/2001 | US6291458 Morpholinobenzamide salts |
| 09/18/2001 | US6291452 Cholecystokinin antagonists. |
| 09/18/2001 | US6291425 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 09/18/2001 | US6291195 Generating ligands which bind preferential human receptors; incubate cells expressing preferential binding protein with modulator, detect adjustment in binding activity |
| 09/18/2001 | US6291175 Methods for treating a neurological disease by determining BCHE genotype |
| 09/18/2001 | US6290994 Beverage containing caffeine or theobromine and vinpocetine citrate for stimulating cerebral activity |
| 09/18/2001 | US6290985 By chewing the gum, the medicament or agent is released from the product. |
| 09/18/2001 | US6290961 Method for treating dystonia with botulinum toxin type B |
| 09/18/2001 | CA2231118C Pharmaceutical preparation containing nimesulide for topical use |
| 09/18/2001 | CA2168364C Stabilized pharmaceutical composition containing bupropion |
| 09/18/2001 | CA2022297C Derivatives of 1,2,3,4-tetrahydro-9-acridinamine |
| 09/15/2001 | WO2001068859A2 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | WO2001066747A2 Proteins named fctrx and nucleic acids encoding same |
| 09/15/2001 | CA2403370A1 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | CA2401552A1 Proteins named fctrx and nucleic acids encoding same |
| 09/13/2001 | WO2001067110A1 Synergistic activation of regulatory elements by rel proteins and a steroid receptor |
| 09/13/2001 | WO2001066746A2 G-protein coupled receptor related polypeptides |
| 09/13/2001 | WO2001066742A2 G-protein coupled receptors |
| 09/13/2001 | WO2001066722A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066716A1 Polypeptide having phosphodiesterase activity |
| 09/13/2001 | WO2001066706A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066698A1 Human cord blood as a source of neural tissue for repair of the brain and spinal cord |
| 09/13/2001 | WO2001066596A2 Human fgf-23 gene and gene expression products |
| 09/13/2001 | WO2001066595A2 Human fgf-23 gene and gene expression products |
| 09/13/2001 | WO2001066594A2 Human protein kinases and protein kinase-like enzymes |
| 09/13/2001 | WO2001066572A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 09/13/2001 | WO2001066564A2 Gamma-secretase inhibitors |
| 09/13/2001 | WO2001066557A1 Adam polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066548A1 New aza-indolyl derivatives |
| 09/13/2001 | WO2001066544A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 09/13/2001 | WO2001066543A2 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives |
| 09/13/2001 | WO2001066540A1 Imidazol-2-carboxamide derivatives as raf kinase inhibitors |
| 09/13/2001 | WO2001066539A1 Imidazol derivatives as raf kinase inhibitors |
| 09/13/2001 | WO2001066525A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | WO2001066521A1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 09/13/2001 | WO2001066164A1 Modified protein matrices |
| 09/13/2001 | WO2001066125A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4) |
| 09/13/2001 | WO2001066120A1 Nerve growth assistance improvement |
| 09/13/2001 | WO2001066114A1 Novel methods using cholinesterase inhibitors |
| 09/13/2001 | WO2001066113A1 Metabotropic glutamate receptor antagonists for treating tolerance and dependency |
| 09/13/2001 | WO2001066107A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | WO2001066100A2 Pharmaceutical composition |
| 09/13/2001 | WO2001066089A2 Pharmaceutical compositions comprising cannabis |
| 09/13/2001 | WO2001066088A1 New self emulsifying drug delivery system |
| 09/13/2001 | WO2001066081A2 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 09/13/2001 | WO2001029178A3 Epo primary response gene 1, eprg1 |
| 09/13/2001 | WO2001028498A3 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 09/13/2001 | WO2001028497A3 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 09/13/2001 | WO2001016288A3 Dna encoding the human serine protease c-e |
| 09/13/2001 | WO2001009169A3 Cysteine protease inhibitors |
| 09/13/2001 | WO2001009138A3 Chemokine receptor antagonists and methods of use therefor |
| 09/13/2001 | WO2000063370A3 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 09/13/2001 | WO2000059886A3 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors |
| 09/13/2001 | US20010021777 Indane or dihydroindole derivatives |
| 09/13/2001 | US20010021758 Drugs, medical diagnosis |
| 09/13/2001 | US20010021722 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| 09/13/2001 | US20010021715 Gastrointestinal disorders |
| 09/13/2001 | US20010021712 Antihistamines, antiallergens, brochodilator agents and antispasmodic agents |
| 09/13/2001 | US20010021700 Vectors, host cells, antibodies, and recombinant and synthetic methods for producing polynucleotides and the polypeptides they encode |
| 09/13/2001 | US20010021695 Administering neurotoxins of botulinum toxin types in an amount to control the duration of therapeutic activity |
| 09/13/2001 | US20010021526 Immortal rho degrees cell line; undifferentiated cells for drug screening; alzheimers, huntington's disease, myoclonic epilepsy lactic acidosis and stroke (MELAS); myoclonic epilepsy ragged red fiber (MERRF) |
| 09/13/2001 | US20010021516 An isolated nucleic acid molecule comprising a polynucleotide having nucleotide sequence atleast 95% identical to a sequence selected from a nucleotide sequence encoding a TRID polypeptide having specific amino acid sequence |
| 09/13/2001 | US20010021400 Tanacetum parthenium extract and method of obtaining same |
| 09/13/2001 | CA2402602A1 Polynucleotides which are of nature b2/d+ a- and which are isolated from e. coli, and biological uses of these polynucleotides and of their polypeptides |
| 09/13/2001 | CA2402341A1 Metabotropic glutamate receptor antagonists for treating tolerance and dependency |
| 09/13/2001 | CA2402179A1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 09/13/2001 | CA2402039A1 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives |
| 09/13/2001 | CA2401549A1 G-protein coupled receptor related polypeptides |
| 09/13/2001 | CA2401541A1 Human protein kinases and protein kinase-like enzymes |
| 09/13/2001 | CA2401525A1 Gamma-secretase inhibitors |